| Main purpose |
Broad gut microbiome ecosystem assessment with translated guidance. |
Detect possible SIBO by measuring breath gas responses after a substrate challenge. |
| Best for |
People seeking gut microbiome context and practical diet/supplement recommendations. |
People focused on whether they may have SIBO and who want breath-gas evidence. |
| Sample type |
Stool sample plus a 3-day food diary (as part of its workflow). |
Breath samples collected before and after ingesting a test substrate. |
| Analysis method |
DNA sequencing-based microbiome profiling (16S DNA sequencing and shotgun metagenomics within its operating system). |
Breath gas measurement (e.g., hydrogen/methane and related markers depending on protocol). |
| What it measures |
Gut microbiome composition/ecosystem signals from stool and dietary context from the diary. |
Breath gas production after a substrate, used as a proxy for fermentation in the small intestine. |
| Pathogens included? |
Not typically positioned as a pathogen panel; focus is broader ecosystem profiling (specific inclusions can vary by report design). |
Generally not a pathogen test; it assesses gas kinetics rather than identifying specific microbes. |
| Functional / microbiome balance insight |
Provides ecosystem-level interpretation and balance-oriented insights using microbiome data and dietary inputs. |
Provides functional fermentation readouts (gas response patterns) rather than microbiome functional mapping. |
| Broad gut health overview |
Yes—designed to give a wide view of gut health rather than one narrow biomarker. |
Limited—primarily focused on a SIBO-related breath response pattern. |
| Personalized recommendations |
Yes—personalized nutrition and probiotic/prebiotic recommendations based on their combined data workflow. |
Usually limited to interpretation of breath results; specific diet/supplement plans depend on the provider/clinic. |
| Nutrition guidance included |
Yes—nutrition guidance tied to the individual’s filled 3-day food diary and recommended adjustments at food-item level with dosing. |
May include general guidance depending on the ordering clinic; breath tests themselves don’t inherently provide food-item dosing plans. |
| Actionability of results |
High—results are translated into practical next steps (diet diary-driven and supplement guidance). |
Moderate—actionability often depends on clinician/provider interpretation and subsequent management plan. |
| Easy-to-understand report |
Consumer-focused, designed to be easier to understand with clear translations of microbiome findings. |
Typically clinician/protocol oriented; interpretation can vary by reporting format. |
| Consumer-friendly vs clinician-focused |
Consumer-friendly with guided recommendations and platform-based translation. |
Often clinician-ordered and interpreted in a medical context. |
|
Yes—DNA-based sequencing allows longitudinal comparisons over time (repeat testing required). |
Sometimes used for follow-up, but repeated breath testing protocols and comparability can vary. |
| Turnaround time |
Varies by lab processing and reporting timelines; typically includes time for sequencing and report generation. |
Often faster for single-visit testing once samples are collected, but final reporting depends on the testing site. |
| Price |
Varies by offering/region; pricing is generally a consumer purchase plus shipping logistics. |
Varies widely by country/clinic and whether it’s provider-led; sometimes covered or discounted depending on healthcare context. |
| Available in Europe / direct-to-consumer |
Available in Europe and offered direct-to-consumer. |
Typically available through clinics; direct-to-consumer availability can vary by country. |
| Data privacy / EU friendliness |
Designed for an EU consumer market; check the company’s stated data handling and consent process for specifics. |
Data handling depends on the clinic/testing provider; privacy practices vary. |